-
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
-
Alleviating Skin Side Effects in Colorectal CancerA clinical trial finds a topical gel can decrease acneiform rash and improve quality of life in people being treated for colorectal cancer.
by Thomas Celona
-
At-home Prostate Cancer Test May Help Some Men Avoid BiopsyThe test, which analyzes urine for 18 cancer-specific genes, ruled out the need for biopsy in men with elevated PSA without a digital rectal exam.
by Sandra Gordon
-
-
Melanoma Risk in Childhood Cancer SurvivorsPeople treated for childhood cancer found to have twice the risk of developing melanoma as an adult.
by Cameron Walker
-
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
-
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
-
Forward Look
Immunotherapy in Advanced Hodgkin LymphomaPatients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.
by Susan Kreimer
-
Forward Look
Rinse and RecurrenceSaliva test can help identify people who are at high risk of recurrence after mouth or throat cancer treatment.
by Eric Fitzsimmons
-
Forward Look
Upfront Immunotherapy in Early-stage Liver CancerResearchers analyze whether giving immunotherapy before surgery benefits people with high-risk disease that is limited to the liver.
by Christina Szalinski
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
